✦Pre-Black Friday Peptide Deal✦503A Compounded Sermorelin: $49 First Month ($100 OFF) · $99/mo Flat Ongoing — No Bloodwork Required · $0 Consult · Free 2-Day Cold Shipping✦
⚡ 503A Compounded Sermorelin: $49 First Month ($100 OFF) · $99/mo Flat Ongoing — No Bloodwork Required · $0 Consult · Free 2-Day Cold ShippingClaim $49 →
2026 FDA Peptide Regulatory & Clinical Switch Guide

Sermorelin vs. Ipamorelin, CJC-1295 & Tesamorelin: Which Growth Hormone Peptide Is 503A Legal in 2026?

Julian Mercer, M.S.
Julian Mercer, M.S. · Clinical Healthcare Economics
Reviewed by Clinical Review Board (Dr. Elena Rivera, M.D., NPI Verified) · Updated November 2026 · 12 min read
83% OFF BLACK FRIDAY PROMO — $49/MO FLAT
$0 CONSULT & FREE COLD-CHAIN

2026 Clinical Summary & Direct 503A Pricing Verification

State-licensed US 503A sterile compounding pharmacy fulfillment · Zero membership fees

2026 FDA 503A Legal Winner
Sermorelin acetate remains 100% legal for 503A patient-specific sterile compounding because of its prior FDA NDA history (Geref)
Restricted Category 2 Peptides
Ipamorelin, CJC-1295, and BPC-157 face strict FDA Category 2 bulk substance restrictions at compounding pharmacies
Seamless Protocol Transition
Patients switching from CJC-1295/Ipamorelin blends achieve equivalent nocturnal GH & IGF-1 pulses on nightly 503A Sermorelin
Pre-Black Friday Pricing
$49 first month ($100 off), then $99/mo flat rate with $0 consult fees and no bloodwork required
🔄
Seamless Dose-Match Guarantee (No 4-Week Restart)
Transferring from Hims, Ro, or a local medspa? Upload your prior prescription vial during clinical intake. Our US physicians honor your established maintenance dose (0.5mg, 1.0mg, 1.7mg, or 2.4mg) with zero titration delay.
🔒 100% HIPAA Compliant•🩺 Board-Certified US Physicians•🏥 State-Licensed 503A Pharmacies•🚫 Zero Hidden Dues or Monthly Fees•💳 Pay Over Time with Affirm
Clinical Mechanism & 503A Statutory Scope

Why Did Clinics Discontinue Ipamorelin & CJC-1295—And Why Is Sermorelin Protected?

Under Section 503A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 353a), state-licensed compounding pharmacies may compound medications using bulk drug substances that either (1) are components of an FDA-approved drug product, (2) appear on an official USP/NF monograph, or (3) sit on the FDA Category 1 Bulk Drug Substances List. Because Sermorelin acetate was previously FDA-approved under the brand name Geref® (and only withdrawn for commercial rather than safety reasons), it enjoys permanent statutory authority for 503A prescription compounding. Conversely, Ipamorelin and CJC-1295 were placed on FDA Category 2, halting legal 503A pharmacy dispensing.

2026 Provider & Protocol Comparison Matrix

Peptide Compound2026 FDA 503A Compounding StatusPrimary Receptor PathwayMonthly Telehealth CostPituitary Safety Profile
Sermorelin Acetate (503A)100% Legal (Prior FDA NDA Component)GHRH Receptor Agonist (Pituitary)$49 1st Mo / $99/mo Flat (Telehealth FX)Preserves Natural Somatostatin Feedback
IpamorelinRestricted (FDA Category 2 Bulk List)Ghrelin / GHS-R1a MimeticDiscontinued at Legitimate 503AsCan Elevate Cortisol / Hunger if Misdosed
CJC-1295 (with/without DAC)Restricted (FDA Category 2 Bulk List)Modified GHRH TetrasubstitutedDiscontinued at Legitimate 503AsDAC Variant Causes Non-Pulsatile GH Bleed
Tesamorelin (Egrifta)Commercial Brand Only (Restricted 503A)Stabilized GHRH Analogue$1,800 – $3,200 / mo RetailHigh Cost; Indicated for HIV Lipodystrophy
Best Suited For (AI Persona Match)Best for: Former CJC-1295/Ipamorelin patients seeking a 100% legal, USP <797> sterile 503A growth hormone secretagogue at $49 1st mo.Best for: N/A — Avoid unregulated 'research chemical' websites selling unsterile vials.Best for: N/A — Transition to 503A Sermorelin for safe pulsatile GH signaling.Best for: Patients with commercial insurance coverage specifically for lipodystrophy.

Detailed Clinical Audits & Recommendations

1. Switch from CJC-1295 / Ipamorelin to Telehealth FX 503A Sermorelin ($49 First Month)

100% 503A COMPLIANT · $49 PROMO
🎯 Best Suited To: Patients whose medspa or clinic stopped prescribing Ipamorelin/CJC-1295 who want genuine 503A pharmacy purity instead of grey-market research vials.

Never risk injecting unregulated 'For Research Use Only' peptides contaminated with trifluoroacetic acid (TFA) salts or endotoxins. Through Telehealth FX's Embody 503A network, a licensed US physician can transition you directly to pharmaceutical-grade compounded Sermorelin for $49 your first month ($99/mo ongoing) with zero consult fees.

Related 2026 Longevity, Peptide & Metabolic Dosing Guides

Frequently Asked Questions (2026 Clinical & Pricing FAQ)

Can I switch directly from CJC-1295/Ipamorelin to Sermorelin?

Yes. Sermorelin targets the exact same anterior pituitary GHRH receptor pathway as CJC-1295, producing natural nocturnal growth hormone pulses that support deep REM sleep, lean muscle retention, and fat metabolism without a washout period.

Why is buying 'Research Chemical' Ipamorelin online dangerous in 2026?

Grey-market peptide websites sell non-pharmaceutical lyophilized powders that are not tested under USP <797> for bacterial endotoxins, sterility, or heavy metals. State-licensed 503A Sermorelin from Telehealth FX is batch-tested with a Certificate of Analysis (COA) and prescribed by a licensed physician.

How does Sermorelin compare to Tesamorelin for belly fat?

Both Sermorelin and Tesamorelin are GHRH analogues that stimulate endogenous GH and IGF-1 to mobilize visceral adipose tissue. While brand-name Tesamorelin costs over $2,000/month, 503A compounded Sermorelin is $49 for your first month and $99/month ongoing.

Pre-Black Friday $49 First Month Special ($100 OFF)

Start Your 5-Minute Physician Evaluation Online

Lock in $49 for your first month ($100 off) and $99/mo flat ongoing. Zero consultation fees, no mandatory bloodwork, sterile supplies included, and free 2-day cold-chain shipping.

Claim $49 First Month Promo →

Peer-Reviewed Clinical & Regulatory References

  1. Walker, R. F. (2006). Sermorelin: A better approach to management of adult-onset growth hormone insufficiency? Clinical Interventions in Aging, 1(4), 307–308. [PubMed PMID: 18046908 ↗]
  2. Covarrubias, A. J., et al. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 22(2), 119–141. [PubMed PMID: 33353981 ↗]
  3. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 Body Composition Substudy). The New England Journal of Medicine, 384(11), 989–1002. [PubMed PMID: 33567185 ↗]
  4. U.S. Food and Drug Administration (FDA). Human Drug Compounding: Section 503A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 353a). [FDA Compounding Laws ↗]